Chempartner Europe in the black

The Chinese-owned contract research organisation, Chempartner Europe, has presented a very modest profit for 2012.

The small Danish contract research organisation (CRO) Chempartner Europe, which is backed by a major parent, has presented a profit for 2012 which is smaller than the previous year.

That is the main headline to be drawn from the recently published annual report for 2012 from the company, which is owned by China Gateway Life Sciences. The Danish company is responsible for European sales of the parent group’s activities in Europe and is based in the Danish town, Hørsholm. At the helm of the company is Peter Halkjær-Knudsen.

Gross profits for 2012 were largely in line with the previous years at DKK 2.3m (USD 408,000), but net profits fell from DKK 219,000 (USD 39,000) in 2011 to DKK 134,000 (USD 24,000) in 2012. Company equity is at DKK 511,000 (USD 90,500).

The company defines the results as satisfactory.

- translated by Martin Havtorn Petersen

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier